Vitamin D and LC-PUFA and the Presence of Fetal Heart Defects-A Further Part of a Case-Control Study维生素D和LC-PUFA与胎儿心脏缺陷的发生——一项病例对照研究的进一步部分NUTRIENTSIF52024-12-240OA
Folic Acid and Selected Risk Factors for Fetal Heart Defects-Preliminary Study ResultsNUTRIENTSIF52024-09-060OAAI
Maternal diet during pregnancy and risk of allergic diseases in children up to 7-9 years old from Polish Mother and Child Cohort studyENVIRONMENTAL RESEARCHIF7.72022-05-0115PRE
Determinants of the Essential Elements and Vitamins Intake and Status during Pregnancy: A Descriptive Study in Polish Mother and Child CohortNUTRIENTSIF52021-03-1611OAAI
Dietary Quality and Dietary Inflammatory Potential During Pregnancy and Offspring Emotional and Behavioral Symptoms in Childhood: An Individual Participant Data Meta-analysis of Four European CohortsBIOLOGICAL PSYCHIATRYIF92021-03-0126OAAI
An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trialPSYCHOPHARMACOLOGYIF3.32019-05-1732OAAI
Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: A secondary outcome analysis of the OFFER randomized controlled studySCHIZOPHRENIA RESEARCHIF3.52018-05-0126PREAI
Telomerase level increase is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: Secondary outcome analysis of the OFFER randomized clinical trialPROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRYIF3.92018-04-0124PREAI
A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophreniaJOURNAL OF PSYCHIATRIC RESEARCHIF3.22016-02-0183PREAI
Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methodsBMC PSYCHIATRYIF3.62015-05-0239OAAI